ABOS News

In the US IPO market’s busiest week since 2004, 19 IPOs raised nearly $10 billion, led by Chinese ride-hailing giant DiDi Global (DIDI). The second largest IPO of the year, DiDi (DIDI) upsized and priced at the high end to raise $4.4 billion at a $70.4 billion market cap. DiDi is China’s dominant ride-hailing app, with 15...read more

Acumen Pharmaceuticals, a Phase 1 biotech developing a monoclonal antibody for Alzheimer's disease, raised $160 million by offering 10 million shares at $16, the high end of the range of $14 to $16. The company offered 1.7 million more shares than anticipated. Acumen Pharmaceuticals believes it is developing a novel approach to Alzheimer's disease (AD) by targeting soluble...read more

17 IPOs are slated to raise $9.1 billion in the week ahead, led by long-awaited Chinese ride-hailing giant DiDi Global (DIDI). DiDi (DIDI) plans to raise $3.9 billion at a $67.5 billion market cap. DiDi is China’s dominant ride-hailing app, with 15 million drivers across 4,000 cities and towns. The unprofitable company saw revenue...read more

Acumen Pharmaceuticals, a Phase 1 biotech developing a monoclonal antibody for Alzheimer's disease, announced terms for its IPO on Thursday. The Charlottesville, VA-based company plans to raise $125 million by offering 8.3 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Acumen Pharmaceuticals would command a fully diluted market value of $607...read more